Online ISSN: 2515-8260

Keywords : oropharyngealcancer accounts for 1.6% of all the new cases and 1.5% deaths in 2020


CLINICAL PROGNOSTIC FACTORS IN OROPHARYNEAL CARCINOMA PATIENTS TREATED WITH CONCURRENT CHEMORADIATION.

Dr Sonali Karnwal, Dr Raja Paramjeet Singh Benipal, Dr Jai Lal, Dr Pardeep Garg, Dr Manraj Singh Kang, Dr Romi Kant Grover

European Journal of Molecular & Clinical Medicine, 2021, Volume 8, Issue 4, Pages 72-78

Worldwide, oropharyngealcancer accounts for 1.6% of all the new cases and 1.5% deaths in 2020. Overall42176, is the incidence of oropharyngeal cancers occuring in Asia, and account for approximately 30% of all the cancers in India. Oropharyngeal carcinoma is eleventh most common cancer worldwide and accounts for approximately 10 per cent of the annual worldwide incidence of head and neck squamous cell carcinoma. In India, head and neck cancers contribute up to 7.8% of the global cancer burden and 8.33% of the global cancer deaths.In 2020, the incidence of oropharynx cancer worldwide is 98,412 1. In India incidence rate is 6794 2. Incidence rates are more than twice as high in men as in women3.The tonsil is the most frequent subsite of oropharyngeal cancer followed by the base of tongue.